Table 2: Overview of the medication used by the different groups at the start of the study.

GroupCPZAtypicalTypicalSSRITricyclic antidepressivesSNRI and SSNRIOthers

Depression and acupuncture groupChlorprothixene in 1 patient
Promethazine in 1 patient
Pipamperone in 1 patient
0.33 in 1 patient
In 2
patients
In 2
patients
In 4
patients
In 3
patients
In 3
patients
In 2
patients

Depression and waitlist groupPipamperone in 1 patient
0.33 in 1 patient
In 1
patient
In 1
patient
In 4
patients
In 2
patients
In 3
patients
In 2
patients

Schizophrenia and acupuncture groupAmisulpride + 1 in 1 patient
Zotepine + 1 in 1 patient
Prothipendyl + 2 in 1 patient
Fluphenazine + 3 in 1 patient
6 in 1 patient
4 in 1 patient
3.5 in 1 patient
1.83 in 1 patient
In 8
patients
In 3
patients
In 0
patients
In 1
patient
In 1
patients
In 4
patients

Schizophrenia and waitlist groupFluphenazine + 3 in 1 patient
6 in 1 patient
Pipamperone + 3.17 in 1 patient
1.83 in 1 patient
1 in 1 patient
Zotepine and Chlorprothixene and Melperone + 4 in 1 patient
10 in 1 patient
3.5 in 1 patient
In 8
patients
In 3
patients
In 0
patients
In 2
patients
In 0
patients
In 4
patients

CPZ (Chlorpromazine Equivalents) were calculated using published equivalencies for oral conventional [19] and atypical [20] antipsychotics.
SSRI: selective serotonin reuptake Inhibitor, SNRI: serotonin norepinephrine reuptake inhibitor, SSNRI: selective serotonin norepinephrine reuptake inhibitor.